Omega Healthcare Investors Inc (OHI)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $14.97B
Last updated: Nov 17, 2026 at 11:06 AM ET
Omega Healthcare Investors Inc (OHI) Financials: Revenue, Profit and Cash Flow
Omega Healthcare Investors reported revenue of $975.06M for the fiscal year ended Dec 31, 2025, up 15.7% from the year before. That year, net income was $609.47M with a net margin of 62.5%, operating cash flow was $878.55M and free cash flow was $797.68M. The quarter ended Jun 30, 2026 had revenue of $526.65M and net income of $379.67M.
Revenue and Margins
The operating margin was 76.9% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $1.73B, a compound annual decline of 6.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $975.06M | +15.7% | 54.7% | 76.9% | 62.5% |
| Dec 2024 | $842.84M | +6.2% | 123.0% | 78.3% | 49.6% |
| Dec 2023 | $793.88M | -21.0% | 117.7% | 61.6% | 31.3% |
| Dec 2022 | $1.00B | +21.4% | 85.8% | 39.0% | 43.7% |
| Dec 2021 | $827.62M | +20.3% | 126.9% | 68.4% | 51.8% |
| Dec 2020 | $688.11M | -11.3% | 127.9% | 65.7% | 23.8% |
| Dec 2019 | $775.81M | +10.0% | 117.8% | 71.1% | 45.4% |
| Dec 2018 | $705.03M | -26.8% | 125.1% | 70.6% | 41.7% |
| Dec 2017 | $963.19M | -44.3% | 94.3% | 32.7% | 10.9% |
| Dec 2016 | $1.73B | N/A | 52.1% | 32.4% | 44.4% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 45.9% from the year before. In the quarter ended Jun 2026, net income rose 170.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $975.06M | $842.84M | $793.88M | $1.00B | $827.62M | $688.11M | $775.81M | $705.03M | $963.19M | $1.73B |
| Cost of revenue | $664.93M | $14.56M | $15.03M | $15.50M | $12.26M | $12.32M | $14.93M | $29.84M | $99.07M | $58.73M |
| Gross profit | $533.17M | $1.04B | $934.72M | $862.74M | $1.05B | $880.07M | $913.90M | $881.68M | $908.38M | $900.83M |
| Operating income | $749.44M | $659.66M | $488.97M | $392.28M | $566.17M | $452.25M | $551.75M | $497.59M | $315.17M | $559.95M |
| Net income | $609.47M | $417.80M | $248.80M | $438.84M | $428.30M | $163.54M | $351.95M | $293.88M | $104.91M | $766.73M |
| EBITDA | $895.60M | $732.46M | $569.70M | $778.61M | $821.67M | $503.89M | $648.37M | $575.70M | $611.46M | $1.21B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $526.65M | $276.22M | $229.13M | $281.75M | $252.50M | $234.58M | $225.96M | $221.10M | $211.69M | $184.09M | $258.53M | $183.25M |
| Gross profit | N/A | $313.94M | $151.95M | $308.09M | $279.25M | $273.47M | $275.87M | $272.46M | $249.00M | $239.50M | $203.19M | $238.14M |
| Operating income | N/A | $207.08M | $204.31M | $206.10M | $179.68M | $156.45M | $175.42M | $182.52M | $166.78M | $134.94M | $184.66M | $134.32M |
| Net income | $379.67M | $158.58M | $171.97M | $184.96M | $140.48M | $112.06M | $116.47M | $114.91M | $117.08M | $69.35M | $56.52M | $93.91M |
Balance Sheet
As of Dec 2025, total debt of $4.26B exceeded cash and equivalents by $4.23B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $10.05B | $9.90B | $9.12B | $9.41B | $9.64B | $9.50B | $9.80B | $17.18B | $8.77B | $8.95B |
| Current assets | $2.06B | $2.64B | $2.23B | $1.77B | $1.39B | $1.39B | $1.23B | $1.20B | $1.50B | $1.64B |
| Cash and equivalents | $27.02M | $518.34M | $442.81M | $297.10M | $20.53M | $163.53M | $24.12M | $20.60M | $85.94M | $93.69M |
| Total liabilities | $4.61B | $5.17B | $5.36B | $5.60B | $5.53B | $5.46B | $5.46B | $4.67B | $4.89B | $4.74B |
| Short-term debt | $242.00M | $0 | $20.40M | $19.25M | $0 | $101.16M | $125.00M | $313.00M | $290.00M | $190.00M |
| Long-term debt | $4.01B | $4.84B | $5.05B | $5.27B | $5.25B | $5.07B | $5.01B | $4.33B | $4.28B | $4.18B |
| Shareholder equity | $5.18B | $4.54B | $3.57B | $3.61B | $3.91B | $3.84B | $4.14B | $3.44B | $3.56B | $3.86B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $10.01B | $10.23B | $10.05B | $10.60B | $10.55B | $9.71B | $9.90B | $9.57B | $8.85B | $9.01B | $9.12B | $9.43B |
| Total liabilities | $4.37B | $4.78B | $4.61B | $5.35B | $5.36B | $4.77B | $5.17B | $5.17B | $4.95B | $5.31B | $5.36B | $5.57B |
| Cash and equivalents | $39.04M | $26.15M | $27.02M | $737.19M | $734.18M | $367.96M | $518.34M | $342.44M | $35.19M | $361.77M | $442.81M | $554.71M |
| Shareholder equity | $5.39B | $5.19B | $5.18B | $5.04B | $4.99B | $4.74B | $4.54B | $4.21B | $3.71B | $3.51B | $3.57B | $3.67B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 90.8% of operating cash flow. Dividends came to 103.3% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $878.55M | $749.43M | $617.74M | $625.73M | $722.14M | $708.26M | $553.75M | $499.37M | $577.91M | $624.77M |
| Capital expenditures | $80.87M | $37.76M | $38.01M | $47.22M | $44.95M | $106.18M | $52.89M | $169.26M | $124.45M | $109.45M |
| Free cash flow | $797.68M | $711.67M | $579.73M | $578.51M | $677.19M | $602.07M | $500.86M | $330.11M | $453.46M | $515.32M |
| Dividends paid | $824.27M | $714.70M | $670.26M | $653.39M | $662.88M | $612.31M | $585.42M | $528.70M | $502.60M | $453.15M |
| Share repurchases | N/A | N/A | N/A | $142.27M | $0 | $0 | N/A | N/A | N/A | N/A |
| Investing cash flow | -$539.79M | -$671.16M | -$770.00K | $442.85M | -$524.17M | -$89.06M | -$378.95M | -$173.22M | -$285.13M | -$1.11B |
| Financing cash flow | -$838.26M | $26.32M | -$473.31M | -$789.45M | -$341.12M | -$485.55M | -$153.96M | -$410.70M | -$303.81M | $576.30M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $217.72M | $215.50M | $230.62M | $226.71M | $239.26M | $181.95M | $228.97M | $184.88M | $184.10M | $151.47M | $164.98M | $171.02M |
| Capital expenditures | $13.85M | $12.82M | $26.69M | $21.23M | $2.31M | $35.25M | $15.48M | $8.27M | $7.44M | $21.45M | $14.71M | $10.11M |
| Free cash flow | $203.87M | $202.68M | $203.93M | $205.48M | $236.95M | $146.70M | $213.49M | $176.62M | $176.67M | $130.03M | $150.27M | $160.91M |
Frequently Asked Questions About OHI
What is Omega Healthcare Investors' annual revenue?
Omega Healthcare Investors reported revenue of $975.06M for the fiscal year ended Dec 31, 2025.
How fast is Omega Healthcare Investors' revenue growing?
Revenue was up 15.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.0%.
Is Omega Healthcare Investors profitable?
Yes. Omega Healthcare Investors reported net income of $609.47M for the fiscal year ended Dec 31, 2025, with a net margin of 62.5%.
How much free cash flow does OHI generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $878.55M minus capital expenditures of $80.87M produced free cash flow of $797.68M.
How much debt does Omega Healthcare Investors have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $4.01B, short-term debt of $242.00M and cash and equivalents of $27.02M.
OHI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors